{"id":"https://openalex.org/W2315499684","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p1-17-10","title":"P1-17-10: Cabozantinib (XL184) in Patients with Metastatic Breast Cancer: Results from a Phase 2 Randomized Discontinuation Trial.","display_name":"P1-17-10: Cabozantinib (XL184) in Patients with Metastatic Breast Cancer: Results from a Phase 2 Randomized Discontinuation Trial.","publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2315499684","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p1-17-10","mag":"2315499684"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs11-p1-17-10","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p1-17-10","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-p1-17-10","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069056507","display_name":"Sara M. Tolaney","orcid":"https://orcid.org/0000-0002-5940-8671","observed_orcids":["https://orcid.org/0000-0002-5940-8671"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"SM Tolaney","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002146164","display_name":"Hovav Nechushtan","orcid":"https://orcid.org/0000-0003-3411-800X","observed_orcids":["https://orcid.org/0000-0003-3411-800X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"H Nechushtan","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063818378","display_name":"Regina Berger","orcid":"https://orcid.org/0000-0003-2952-6797","observed_orcids":["https://orcid.org/0000-0003-2952-6797"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"R Berger","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"R Kurzrock","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111645287","display_name":"IG Ron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"IG Ron","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021550191","display_name":"Patrick Sch\u00f6ffski","orcid":"https://orcid.org/0000-0001-5980-030X","observed_orcids":["https://orcid.org/0000-0001-5980-030X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"P Scho\u0308ffski","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010064853","display_name":"Ahmad Hussein Awada","orcid":"https://orcid.org/0000-0001-7412-9163","observed_orcids":["https://orcid.org/0000-0001-7412-9163"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"A Awada","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004442431","display_name":"CA Yasenchak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"CA Yasenchak","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109205440","display_name":"HA Burris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"HA Burris","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028432457","display_name":"DA Ramies","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"DA Ramies","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039888719","display_name":"XuChaoyan Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"X Shen","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["BE","IL","US"],"is_corresponding":false,"raw_author_name":"EP Winer","raw_affiliation_strings":["1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","Dana Farber Cancer Institute, Boston, MA","Exelixis, Inc., South San Francisco, CA","Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","Institut Jules Bordet, Brussels, Belgium","MD Anderson Cancer Center, Houston, TX","Northwest Cancer Specialists, P.C., Tualatin, OR","Sarah Cannon Research Institute, Nashville, TN","Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana Farber Cancer Institute, Boston, MA; Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel; The Chaim Sheba Medical Center, Tel Hashomer, Israel; MD Anderson Cancer Center, Houston, TX; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium; Institut Jules Bordet, Brussels, Belgium; Northwest Cancer Specialists, P.C., Tualatin, OR; Sarah Cannon Research Institute, Nashville, TN; Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861","https://openalex.org/I2799807261","https://openalex.org/I2799810450","https://openalex.org/I2801838318","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Exelixis, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I152988861"]},{"raw_affiliation_string":"Hadassah Ein-Kerem Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Northwest Cancer Specialists, P.C., Tualatin, OR","institution_ids":[]},{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]},{"raw_affiliation_string":"Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]},{"raw_affiliation_string":"Universitaire Ziekenhuis Gasthuisberg, Leuven, Flemish Brabant, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4319,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.65845831,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"71","issue":"24_Supplement","first_page":"P1","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5278000235557556,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5278000235557556,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.16500000655651093,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.04910000041127205,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/met-inhibition","display_name":"MET inhibition","score":0.7739999890327454},{"id":"https://openalex.org/keywords/vegfr-2-inhibition","display_name":"VEGFR-2 inhibition","score":0.984000027179718},{"id":"https://openalex.org/keywords/vegf-signaling","display_name":"VEGF signaling","score":0.6230000257492065},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.7020000219345093},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.7960000038146973},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6729999780654907},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9900000095367432},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.6690000295639038},{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":0.8149999976158142},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7210000157356262},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.531000018119812},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.9667045474052429},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8323556780815125},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6342336535453796},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6286810636520386},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5759372115135193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5714272856712341},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5665345191955566},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5110701322555542},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4929778575897217},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46048057079315186},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.460233211517334},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3649895191192627},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3586346507072449},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18069693446159363}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs11-p1-17-10","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p1-17-10","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-p1-17-10","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2188135389","https://openalex.org/W2528809664","https://openalex.org/W2468601751","https://openalex.org/W2312509434","https://openalex.org/W3029507093","https://openalex.org/W2601097060","https://openalex.org/W2587365868","https://openalex.org/W2319216644","https://openalex.org/W2798901554","https://openalex.org/W2940550565"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Cabozantinib":[2,438,466],"is":[3,467,475],"an":[4,425],"oral,":[5],"potent":[6],"inhibitor":[7],"of":[8,24,42,59,78,113,225,240,263,273,290,327,376,393,417,447,458],"MET":[9,12,44],"and":[10,26,45,128,196,215,255,311,317,325,341,378,406,430,449,461,471],"VEGFR2.":[11],"overexpression":[13],"has":[14,91],"been":[15,93],"observed":[16,84,353],"in":[17,34,74,211,219,323,354,422,442],"metastatic":[18],"breast":[19,38],"cancer":[20],"(MBC).":[21],"High":[22],"levels":[23],"VEGF":[25,46],"its":[27],"receptors":[28],"are":[29,435],"associated":[30,94],"with":[31,37,49,67,95,126,177,182,186,198,236,252,280,358,444,480],"poor":[32],"prognosis":[33],"patients":[35],"(pts)":[36],"cancer.":[39],"Simultaneous":[40],"targeting":[41],"the":[43,212,220,472],"signaling":[47],"pathways":[48],"cabozantinib":[50,69,90,133,193],"may":[51],"therefore":[52],"be":[53],"a":[54,60,75,140,237],"promising":[55],"treatment":[56,150,451],"strategy.":[57],"Results":[58],"phase":[61],"2":[62,407],"randomized":[63,191,221],"discontinuation":[64],"trial":[65],"(RDT)":[66],"single-agent":[68,132],"have":[70],"demonstrated":[71],"clinical":[72,440],"activity":[73,441],"broad":[76],"range":[77],"tumor":[79,350,361,459],"types.":[80],"In":[81],"addition":[82],"to":[83,147,192,477],"effects":[85,96,462],"on":[86,97,174,383,463],"soft":[87],"tissue":[88,331],"lesions,":[89],"also":[92],"bone":[98,106,226,285,369,385,399,432,464],"metastases":[99],"as":[100,387,389,453],"exhibited":[101],"by":[102,368,455],"partial":[103,178,374],"or":[104,123],"complete":[105],"scan":[107,370],"resolution,":[108],"pain":[109,405],"relief":[110],"and/or":[111],"reduction":[112],"narcotic":[114,411],"use.":[115],"Methods:":[116],"MBC":[117,155,232,445],"pts":[118,176,233,245,264,274,356,366,395,402,408,418,443],"(ER":[119],"[+],":[120],"triple":[121],"[-]":[122],"inflammatory":[124,253],"subtype)":[125],"progressive":[127,199],"measurable":[129],"disease":[130,188,200,277,343],"received":[131,296],"at":[134,371],"100":[135],"mg":[136],"qd":[137],"PO":[138],"over":[139],"12":[141,171],"week":[142],"(wk)":[143],"lead-in":[144,213],"period.":[145,222],"Up":[146],"4":[148],"prior":[149,291,297,450],"regimens":[151,292],"(hormonal":[152],"excluded)":[153],"for":[154,320,398],"were":[156,190,201,228,234,265,269,308],"allowed.":[157],"Tumor":[158],"response":[159,179,208],"was":[160,172,206,293,339,347,352],"assessed":[161],"every":[162],"6":[163],"wks":[164],"per":[165,337,413],"mRECIST":[166],"1.0.":[167],"Treatment":[168],"beyond":[169],"wk":[170,334],"based":[173],"response:":[175],"(PR)":[180],"continued":[181],"open-label":[183],"cabozantinib,":[184],"those":[185,197],"stable":[187],"(SD)":[189],"vs.":[194],"placebo,":[195],"discontinued.":[202],"The":[203,287,415],"primary":[204],"endpoint":[205],"objective":[207],"rate":[209,345,457],"(ORR)":[210],"period,":[214],"progression":[216],"free":[217],"survival":[218],"Post-hoc":[223],"evaluations":[224],"scans":[227,386],"conducted.":[229],"Results:":[230],"20":[231],"enrolled":[235],"median":[238,288],"age":[239],"55":[241],"years":[242],"(range:":[243],"31\u201371).19":[244],"had":[246,258,275,284,373,381,409,420],"invasive":[247,259],"ductal":[248],"carcinoma":[249],"(1":[250],"pt":[251,257,380],"MBC),":[254],"1":[256],"lobular":[260],"carcinoma.":[261],"75%":[262],"ER/PR":[266],"[+];":[267],"15%":[268,326],"HER2/neu":[270],"[+].":[271],"85%":[272],"visceral":[276],"including":[278],"65%":[279],"liver":[281],"metastases;":[282],"70%":[283],"disease.":[286],"number":[289],"3;":[294],"45%":[295],"anti-VEGF":[298],"therapy.":[299],"Most":[300],"common":[301],"related":[302],"adverse":[303],"events":[304],"\u2265":[305],"Grade":[306],"3":[307,401],"fatigue/asthenia,":[309],"20%;":[310],"hand-foot":[312],"syndrome,":[313],"20%.":[314],"Dose":[315],"reductions":[316],"permanent":[318],"discontinuations":[319],"AEs":[321],"occurred":[322],"35%":[324],"pts,":[328],"respectively.":[329],"Soft":[330],"effects:":[332,364],"At":[333],"12,":[335],"ORR":[336],"RECIST":[338],"10%":[340],"overall":[342],"control":[344],"(PR+SD)":[346],"45%.":[348],"Notably,":[349],"shrinkage":[351],"15/16":[355],"(94%)":[357],"\u22651":[359],"post-baseline":[360],"assessment.":[362],"Bone":[363],"2/3":[365],"evaluable":[367],"baseline":[372],"resolution":[375],"lesions":[377],"one":[379],"SD":[382],"follow-up":[384],"early":[388],"Wk":[390],"6.":[391],"Out":[392],"7":[394],"receiving":[396],"narcotics":[397],"pain,":[400],"reported":[403],"improved":[404],"decreased":[410],"use,":[412],"investigator.":[414],"majority":[416],"analyzed":[419],"declines":[421],"plasma":[423],"CTx,":[424],"osteoclast":[426],"marker.":[427],"Additional":[428],"enrollment":[429],"further":[431],"marker":[433],"analyses":[434],"ongoing.":[436],"Conclusions:":[437],"exhibits":[439],"regardless":[446],"receptor":[448],"status":[452],"reflected":[454],"high":[456],"regression":[460],"metastases.":[465],"generally":[468],"well":[469],"tolerated":[470],"safety":[473],"profile":[474],"comparable":[476],"that":[478],"seen":[479],"other":[481],"tyrosine":[482],"kinase":[483],"inhibitors.":[484],"Citation":[485],"Information:":[486],"Cancer":[487],"Res":[488],"2011;71(24":[489],"Suppl):Abstract":[490],"nr":[491],"P1-17-10.":[492]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}